What are the best indications ?

Prostate cancer is an illness that develops slowly. Unfortunately, it develops quietly and most of the time sufferers have no symptoms. It is possible to have the illness for several years without knowing it. Unfortunately, patients sometimes learn of their cancer when it has reached an advanced stage and has already spread throughout their body and away from the prostate as metastases. However, novel techniques for early testing allow for the illness to be detected much sooner so patients can begin treatment with much more favourable prognostics. The indications for Ablatherm HIFU are patients who are diagnosed at an early stage with a moderately aggressive cancer.

Therefore, it is widely accepted that the best indications are patients who are suffering from cancer at a maximum of the localised T2c stage, without metastases, a PSA lower than 15 and a Gleason score lower than 8. The better these indicators, the greater the chances of a cure (94% for patients with a PSA of 7, a Gleason of 3 and cancer at stage T2a).